title: Both peak and late aggregation are capable of identifying patients at risk for atherothrombotic events.
authors.forename: Nicoline J
authors.initials: NJ
authors.lastname: Breet
authors.forename: Jochem W
authors.initials: JW
authors.lastname: van Werkum
authors.forename: Heleen J
authors.initials: HJ
authors.lastname: Bouman
authors.forename: Johannes C
authors.initials: JC
authors.lastname: Kelder
authors.forename: Jurriën M
authors.initials: JM
authors.lastname: Ten Berg
authors.forename: Christian M
authors.initials: CM
authors.lastname: Hackeng
mesh_terms: D006801:Humans; D010975:Platelet Aggregation Inhibitors; D010979:Platelet Function Tests / Q000379:methods / Q000592:standards*; D012372:ROC Curve; D016019:Survival Analysis; D013927:Thrombosis / Q000175:diagnosis*
chemical_list: D010975:Platelet Aggregation Inhibitors